CCL2 and systemic sclerosis: MCP-1 (CCL2) is one of the most robustly described chemokines with an established role in mediating fibrotic immune responses in SSc, and its levels are increased in SSc serum, skin, and bronchoalveolar lavage (BAL) fluid [29].